ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.54 2.2M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 4.05p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.20 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.54.

Evgen Pharma Share Discussion Threads

Showing 7726 to 7747 of 13025 messages
Chat Pages: Latest  317  316  315  314  313  312  311  310  309  308  307  306  Older
DateSubjectAuthorDiscuss
11/3/2021
15:48
.. and it's not down to Finncap, because SNG and others seem to have done just fine with them.
on target
11/3/2021
15:44
Yep, and Evolution weren’t the whitest of white when it came to stock braking, market making etc..!
bumpa33
11/3/2021
15:34
That is interesting, Bumpa. I did not know that about RG.
Anyway, I am pleased that Octopus came on board, a name that I also have a lot of respect for. GLA.

lovewinshatelosses
11/3/2021
15:20
Diluted yes, rather depends on how the cash is utilized though no? We’re priced with almost zero regard to potential. So you either see a mad pricing anomaly or you agree that this has zero potential.

It is a frustrating wait I’ll grant you.

bumpa33
11/3/2021
15:16
mesquida - it is what it is with Finncap. If you can name me a better broker (morals, integrity etc etc) at the lower end of the food chain, I’d be amazed.
bumpa33
11/3/2021
14:41
LOL so the tale of intrigue gets even more intriguing.

So let's recap. Huw had a zoom call with nico115 and told him he wanted £3m. But then Finncap decided to play a nasty trick on Huw and went and raised £10m instead! What a jolly jape. Then poor Huw had to quickly make up all that stuff about how he would spend the £10m. Have I got this right?

on target
11/3/2021
13:19
Lwhl - Griffith was founder of long departed Evolution - bought out by Investec many moons ago - he’s a trader by nature. He’s had his share of success and failures over the years, but then ain’t we all.
bumpa33
11/3/2021
13:12
Nico turning up on this BB is the biggest negative that I see also!
brasso3
11/3/2021
13:07
I can find one negative moneymunch - nico says he has 2 million shares in Evgen, that he is considering selling. Or has he changed his mind? :-)
clocktower
11/3/2021
13:03
It's hard to find many negatives with so much cash in the bank with so many shots on multiple targets, the oversubscribed £11m fund raise speaks volumes imho, and suggests that the new high quality sharholders such as Octopus must be highly confident of Evgen's prospects and potential going forward, and more disclosures to come in the coming days. Evgen now has c£13m cash which is a subtantial amount commensurate to their current value, and allows Huw and the team to accelerate development of the pipeline and grow the company for the next couple of years, which offers a very exciting risk/reward opportunity and tremendous upside potential on success, for all invested. Gla ;-)
moneymunch
11/3/2021
12:24
It is what it is I was on the zoom so I heard first hand how much money they were looking to raise
nico115
11/3/2021
11:45
Yes, first hurdle clear and as you say Bumpa, nothing unexpected, so no surprises to see little movement in the share price today. Was nervous before I opened the RNS though.
Nice to have a clear indication of when we will get the news that will either light the touch paper, or cause discomfort, from the reviewed data of this trial.
Hopefully we will enjoy a nice rise as we approach that period.
While I would have also liked to see RG increase his position here, I remember him dumping stock in other shares that went on to rocket shortly afterwards, so while he is clearly an impressive investor, he does not always get it right! I certainly hope he is wrong here :)
A part of me also hopes he is wrong with his increased holding of C4X, which I mentioned being tied up here at the time meant I did not have the cash available to invest there, when the share price was something like 16p.
Laugh and the whole world laughs with you - apparently! GLA.

lovewinshatelosses
11/3/2021
11:04
There's no need for recollections here, we have RNSs. Unless nico reckons he heard Huw talking about raising £3m (or was it £5m like he said in his first post) down the pub?
on target
11/3/2021
10:42
As the Queen has suggest about Meghan's comments - On Target - Different recollections
clocktower
11/3/2021
10:16
Says it like it is, apart from making up stuff about the placing.
on target
11/3/2021
10:10
Say it like it is nico115. Nice positive sounds from you today - "Limited downside now"
If that's not a buy signal from you, what is. :-)

clocktower
11/3/2021
08:13
good news on safety, though not unexpected. The next one is the big one.
bumpa33
11/3/2021
07:43
Positive interim efficacy data on SFX-01 for Covid/Ards from Prof Chalmers will be a complete game changer, undoubted transformational upside potential on multiple fronts and fully funded for the forseeable......a very attractive risk/reward opportunity from this current rock bottom low. Gla ;-)
moneymunch
11/3/2021
07:41
After my earlier pessimism, I received 70% of my excess (27913/40000), which is more than I expected.
ewanwhose
11/3/2021
07:34
Good rns today Limited downside now Let's agree to disagree about director buys as free bet for them which is wrong
nico115
11/3/2021
07:20
Prof Chalmers, Lead investigator for SFX-01 Covid/ARDS patient trials, is on the organisation committee for the following event, and so every chance that he could be reporting good news on SFX-01's efficacy for Covid/Ards 29th April 2021.Gla ;-)

COVID-19: State of the art – DRAGON IMI project
29 April, 2021 Online

A full-day virtual event dedicated to COVID-19, where top level faculty will share the latest advances, data and best practices relating to SARS-CoV-2 and COVID-19.

“This event brings together world-leaders tackling COVD-19 and how different digital approaches to big data will help us to defeat the pandemic” – Professor Christopher Brightling, event co-chair.

moneymunch
Chat Pages: Latest  317  316  315  314  313  312  311  310  309  308  307  306  Older

Your Recent History

Delayed Upgrade Clock